There are several TET2 targets in T-ALL that overlap with AML, such as CCDC84, CHKA, GNGT2, GPS2, IL20RB, LIN7B, PPAN, PROCA1, RECQL4, TMSB10, CHKB (fusion), and PABPN1 (fusion). This evidence concerns the gene GNGT2 and acute lymphoblastic leukemia.